EUVIMEDEUVIMED entdecken
Crossref

Development and Preclinical Evaluation of [68Ga]Ga-DOTA-L3: A Novel PET Tracer for Quantitative Imaging of Carbonic Anhydrase IX

Jie Li iD, Yuhui Luo, Chengyu Luo, Zixin Yang, Fei Luo, Huajian Gu, Fei Chen, Zongxi He, Suping Li

Molecular Pharmaceutics · 02.11.2026 · 23 (11) · 5787-5798

DOI: 10.1021/acs.molpharmaceut.6c00836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.09.2026. Verfasst von Jie Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: North Sichuan Medical College, Sichuan637100, China. Hauptthemen laut MEDLINE: Carbonic Anhydrase IX, Gallium Radioisotopes, Radiopharmaceuticals, Antigens, Neoplasm. Die Arbeit nennt 44 Literaturangaben. Gefördert von: North Sichuan Medical College, Department of Science and Technology of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbonic anhydrase IX (CA IX) is a key biomarker for tumor hypoxia and a promising target for molecular imaging. In this study, we developed [68Ga]Ga-DOTA-L3, a novel small-molecule CA IX-targeted PET tracer. The radiolabeling was optimized to consistently achieve a radiochemical purity of >98% (10 μg precursor, 90 °C, pH 4.5, 10 min), with excellent stability in saline and FBS up to 240 min. In vivo studies demonstrated rapid blood clearance and predominant renal excretion. Surface plasmon resonance analysis demonstrated high-affinity binding of the DOTA-L3 precursor toward CA IX (Kd = 7.60 ± 0.37 nM) with highest affinity observed for CA IX among the tested isoforms. MicroPET/CT imaging (30−240 min p.i.) showed robust tumor accumulation in OSRC-2 (SUVmean = 1.47 ± 0.21) and HT-29 (SUVmean = 1.03 ± 0.12) xenografts, while minimal uptake was observed in CA IX-low FTC-238 tumors (SUVmean = 0.21 ± 0.05) at 60 min p.i. PET-derived tumor uptake showed a strong linear correlation with CA IX expression levels (R2 = 0.976, P < 0.001) across the three tumor models. High tumor-to-muscle and tumor-to-blood ratios further confirm favorable imaging contrast (T/M = 27.53 ± 1.89 and T/B = 24.61 ± 2.35 at 240 min p.i. for OSRC-2 model). These results support [68Ga]Ga-DOTA-L3 as a promising candidate for non-invasive assessment of CA IX-associated hypoxia and as a scaffold for future theranostic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase IXGallium RadioisotopesRadiopharmaceuticalsAntigens, NeoplasmPositron-Emission TomographyAnimalsHumansMiceTissue DistributionMolecular ImagingCell Line, TumorFemalePositron Emission Tomography Computed TomographyMice, Nude

Stichwörter der Autor:innen

PET imagingcarbonic anhydrase IX (CA IX)gallium-68-labeled tracerradiolabeling optimizationsmall-molecule tracer

Substanzen

Carbonic Anhydrase IXGallium RadioisotopesRadiopharmaceuticalsAntigens, NeoplasmCA9 protein, humanGallium-68

Autor:innen und Institutionen

  • North Sichuan Medical College, Sichuan637100, China.
  • The Affiliated Hospital of North Sichuan Medical College, Sichuan637000, China.
  • Nuclear Medicine and Radiation Safety Key Laboratory of Sichuan Province, North Sichuan Medical College, Sichuan637100, China.
  • Medical Imaging Key Laboratory of Sichuan Province, North Sichuan Medical College, Sichuan637100, China.

ORCID-Profile: Jie Li

Förderung

  • North Sichuan Medical College
  • Department of Science and Technology of Sichuan Province

Zitieren

APA

Li, J., Luo, Y., Luo, C., Yang, Z., Luo, F., Gu, H., Chen, F., He, Z., & Li, S. (2026). Development and Preclinical Evaluation of [68Ga]Ga-DOTA-L3: A Novel PET Tracer for Quantitative Imaging of Carbonic Anhydrase IX. Molecular Pharmaceutics, 23(11), 5787-5798. https://doi.org/10.1021/acs.molpharmaceut.6c00836

Vancouver

Li J, Luo Y, Luo C, Yang Z, Luo F, Gu H, et al. Development and Preclinical Evaluation of [68Ga]Ga-DOTA-L3: A Novel PET Tracer for Quantitative Imaging of Carbonic Anhydrase IX. Molecular Pharmaceutics. 2026;23(11):5787-5798. doi:10.1021/acs.molpharmaceut.6c00836

BibTeX
@article{Li2026,
  author = {Li, Jie and Luo, Yuhui and Luo, Chengyu and Yang, Zixin and Luo, Fei and Gu, Huajian and Chen, Fei and He, Zongxi and Li, Suping},
  title = {Development and Preclinical Evaluation of [68Ga]Ga-DOTA-L3: A Novel PET Tracer for Quantitative Imaging of Carbonic Anhydrase IX},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {11},
  pages = {5787--5798},
  doi = {10.1021/acs.molpharmaceut.6c00836}
}
Kostenlos starten →